Keywords: medeva, takes, single, isomer, methylphenidate, exercised, its
Medeva Takes On Single Isomer Methylphenidate
Article | 27 January 1997
Medeva has exercised its option to proceed with full clinicaldevelopment of Chiroscience's d-threo isomer of methylphenidate after a successful Phase ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
